The Chemours Co. (CC)

51.08
NYSE : Process Industries
Prev Close 50.14
Day Low/High 50.41 / 51.59
52 Wk Low/High 32.09 / 58.08
Avg Volume 2.05M
Exchange NYSE
Shares Outstanding 185.16M
Market Cap 9.26B
EPS 4.00
P/E Ratio 12.82
Div & Yield 0.68 (0.24%)

Latest News

The Chemours Company Hosts First Investor Day

The Chemours Company Hosts First Investor Day

Announces >5 Times Increase in Quarterly Dividend, $500 million Share Repurchase Plan and New Growth Expectations through 2020

Jobs Plus Earnings Equal Buys: Cramer's 'Mad Money' Recap (Friday 11/3/17)

Jobs Plus Earnings Equal Buys: Cramer's 'Mad Money' Recap (Friday 11/3/17)

Will the benign backdrop continue next week? Cramer has a defensive game plan, in case earnings chill the market.

Dow Marks New Record as Trump Plays it Safe With Powell as Fed Pick

Dow Marks New Record as Trump Plays it Safe With Powell as Fed Pick

Stocks hold mixed on Thursday, Nov. 2, after President Donald Trump names Jerome Powell as his pick for Federal Reserve chair.

Stocks Hold Mixed After Trump Names Powell as Fed Chair Nominee

Stocks Hold Mixed After Trump Names Powell as Fed Chair Nominee

Stocks hold mixed on Thursday, Nov. 2, after President Donald Trump names Jerome Powell as his pick for Federal Reserve chair.

Chemours Announces Plan To Build Innovation Center At University Of Delaware's Science Technology And Advanced Research Campus

Chemours Announces Plan To Build Innovation Center At University Of Delaware's Science Technology And Advanced Research Campus

Government Officials Hail Decision as a Major Economic and Academic Development Win for the State

'Lock and Roll' on Chemours

'Lock and Roll' on Chemours

We'll roll our CC profits into a November call spread.

Opteon™ 1100 Wins 2017 Polyurethane Innovation Award

Opteon™ 1100 Wins 2017 Polyurethane Innovation Award

The Low GWP Foam Blowing Agent by Chemours Won the Innovation Award sponsored by the Center for the Polyurethanes Industry (CPI)

Chemours Has the Right Chemistry

Chemours Has the Right Chemistry

The stock has been having a good year, but it's breaking out higher today.

Opteon™ XL40 Honored At The RAC Cooling Industry Awards

Opteon™ XL40 Honored At The RAC Cooling Industry Awards

The Low GWP Refrigerant by Chemours Won the Cold Chain Project Award for a 404A Transition Project with Dawsonrentals

Sometimes You Crave 'Junk Food' -- Even When Investing

Sometimes You Crave 'Junk Food' -- Even When Investing

At Libbey, the glass may be half empty, but it's likely to fill up again.

Sometimes You Crave 'Junk Food'

Sometimes You Crave 'Junk Food'

At Libbey, the glass may be half empty, but it's likely to fill up again.

Chemours Responds To EPA 2015 Ruling To Regulate HFCs

Chemours Responds To EPA 2015 Ruling To Regulate HFCs

Chemours supports EPA's authority under the Clean Air Act to change the status of high-GWP alternatives to unacceptable

Saber-Rattling Sparks Selling

VIX climbs while gold and bonds catch a bid.

Tesla and Apple Better Deliver Big-Time or Look Out Below -- Week Ahead

Tesla and Apple Better Deliver Big-Time or Look Out Below -- Week Ahead

The labor market goes under inspection and Apple releases its earnings report.

Tesla's Rally Has Died: Stock Falls to Sixth Worst Performer in Russell 1000

Tesla's Rally Has Died: Stock Falls to Sixth Worst Performer in Russell 1000

It was the seventh best performer in the index during the first half of the year.

New Tronox Chairman Faces Test at Coatings and Pigments Maker

New Tronox Chairman Faces Test at Coatings and Pigments Maker

Ilan Kaufthal arrives while Tronox's acquisition of Cristal's titanium dioxide assets is under FTC review.

These Stocks Have Changed Direction

These Stocks Have Changed Direction

Finding bullish and bearish reversals in the market.

Apple Is a Very Strong Brand, and Jim Cramer Is Sticking With the Stock: Mad Money

Apple Is a Very Strong Brand, and Jim Cramer Is Sticking With the Stock: Mad Money

Go inside Jim Cramer's Apple call.

Charles Schwab, Essent Group, Cara Therapeutics, MGM Growth Properties: 'Mad Money' Lightning Round

Charles Schwab, Essent Group, Cara Therapeutics, MGM Growth Properties: 'Mad Money' Lightning Round

Jim Cramer is bullish on Charles Schwab, Essent Group, Cara Therapeutics, and MGM Growth Properties.

TheStreet Quant Rating: C+ (Hold)